Hybrid Fuels, Inc. Announces Name Change to Nouveau Life Pharmaceuticals, Inc.
New Trading Symbol of NOUV
FORT LAUDERDALE, Fla., May 30, 2012 /PRNewswire/ -- Nouveau Life Pharmaceuticals, Inc. (Pink Sheets: NOUV) completed a corporate action to change its name from Hybrid Fuels, Inc. The name change was approved by FINRA and became effective on May 22, 2012. The trading symbol for the Company was also changed from HRID to NOUV.
The name Nouveau Life Pharmaceuticals more clearly represents the Company's business focus of developing nutraceuticals and all-natural supplements. The Company recently developed a strategic plan to aggressively expand its signature New Life Naturals™ line of supplements in order to meet the wide ranging needs of the roughly 150 million Americans who regularly use dietary supplements.
About Nouveau Life Pharmaceuticals
The Company, formerly known as Hybrid Fuels, Inc., was incorporated in the state of Nevada in 1998 as Polo Equities. It has primarily been a development stage company with management focused on developing innovative business opportunities and further advancing technologies.
The Company, formerly known as Hybrid Fuels, Inc., was incorporated in the state of Nevada in 1998 as Polo Equities. It has primarily been a development stage company with management focused on developing innovative business opportunities and further advancing technologies.
Forward-Looking Statements - This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties that could cause future results to differ materially from the forward-looking statements. You should consider these factors in evaluating the statements herein, and not rely on such statements. The forward-looking statements in this release are made as of the date hereof and Hybrid Fuels, Inc. undertakes no obligation to update such statements.
CONTACT:
Nouveau Life Pharmaceuticals, Inc. - 954-903-2993
SOURCE Nouveau Life Pharmaceuticals, Inc.
No comments:
Post a Comment